SMHGF (SMHGF PINK) stock market data APIs
$1.9457
0(0%)
as of February 4, 2026
Try our APIs with
free plan!
SMHGF Financial Data Overview
Price chart is built with
Anychart
Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN simnotrelvir tablets and ritonavir tablets. The company also offers promotional services for pharmaceutical products. In addition, it engages in the manufacture of pharmaceutical ingredients and its property management business. The company was founded in 1995 and is headquartered in Nanjing, China.
Prev. Close
1.9457
Open
1.9457
High
1.9457
Low
1.9457
52 wk Range
0.6699-1.96
Market Cap
5 066 M
P/E Ratio
39.2
Shares Outstanding
2 585 M
Revenue
7 107 M
Dividends (Yield)
0.0816
Beta
0.895
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SMHGF data using free add-ons & libraries
Get SMHGF Fundamental Data
SMHGF Fundamental data includes:
- Net Revenue: 7 107 M
- EBITDA: 1 485 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SMHGF News
New
3 Asian Stocks Estimated To Be Undervalued By Up To 31.5%
As global markets navigate a complex landscape marked by steady interest rates and fluctuating consumer confidence, investors are increasingly turning their attention to Asia, where economic resilienc...
3 Asian Stocks That Might Be Priced Below Their Estimated Value
As the Asian markets navigate a landscape marked by political shifts and economic recalibrations, investors are keenly observing opportunities that may arise from these evolving conditions. In this co...
Global Market Gems 3 Stocks That Could Be Priced Below Fair Value Estimates
As global markets navigate a complex landscape marked by unchanged interest rates from the Federal Reserve, fluctuating consumer confidence, and modest economic recovery in the eurozone, investors are...
3 Asian Stocks That May Be Trading Up To 43.8% Below Intrinsic Value Estimates
As global markets navigate a landscape of steady interest rates and fluctuating consumer confidence, Asian stocks present intriguing opportunities for investors seeking value. In this environment, ide...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
